SCHEMBL14748488

SCHEMBL14748488

CC1(C)CCc2c(c(Cl)n3c(nc4ccccc43)c2C2CN2)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
NPSR1 Q6W5P4 3/20 0.34
RAB9A P51151 2/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
MDM2 Q00987 1/20 0.34
HSP90AA1 P07900 1/20 0.33
PDE4B Q07343 1/20 0.33
KMT2A Q03164 3/20 0.32
HPGD P15428 3/20 0.32
HTT P42858 2/20 0.32
ALDH1A1 P00352 3/20 0.32
MEN1 O00255 2/20 0.32
KDM4E B2RXH2 3/20 0.32
POLB P06746 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
XBP1 P17861 1/20 0.32
CACNA1G O43497 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14748400 0.78 MAPT (0.33) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14728254 0.78 MAPT (0.52) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14728264 0.77 PDE4B (0.53) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14728253 0.71 MAPT (0.56) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14748458 0.71 MAPT (0.37) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14716115 0.69 PDE4B (0.59) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14748490 0.66 MAPK1 (0.48) MAPTSMN1; SMN2NPSR1RAB9ALMNA
SCHEMBL14728610 0.65 MAPK1 (0.47) MAPTSMN1; SMN2NPSR1LMNAKMT2A
SCHEMBL14748471 0.63 MAPK1 (0.38) NPSR1LMNAPDE4BKMT2AHPGD
SCHEMBL14728525 0.63 MAPK1 (0.54) MAPTSMN1; SMN2NPSR1LMNAPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2565194-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE Astellas Pharma Inc. (JP) 2013-03-06 EP disclosed